Center for Clinical Trials of San Gabriel

West Covina, California 91790-3402

1 studies enrolling now · 10 studies all time

What they study most

Acute Gout, Arthritis, Rheumatoid, Diabetes Mellitus, Type 2, Influenza, Measles, Measles-Mumps-Rubella+Chickenpox Vaccine, Mumps, Non-Eosinophilic Asthma, Pneumococcal Disease, Pneumococcal Vaccines, Rubella, Varicella (Chickenpox)

Studies at this site

• A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age — Starting soon
• A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma. — Completed
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes — Completed
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
• Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years) — Completed
• Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. — Completed
• Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients — Completed